{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:24:08Z","timestamp":1769156648461,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The declaration of the coronavirus disease (COVID-19), a pandemic in early 2020, has seen an upsurge in research globally to fill gaps in the epidemiology of the SARS-CoV-2 virus impact on health care and clinical management, as well as possible prevention and treatment modalities. Published literature on the different types of COVID-19 research conducted globally is varied and is particularly limited in Africa. This study sets out to describe the COVID-19-related research registered and conducted on the African continent.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a cross-sectional study of all COVID-19-related studies available in the WHO\u2019s International Clinical Trials Registry Platform (ICTRP) repository. We extracted studies registered from March 1, 2020, to July 15, 2021. A descriptive analysis of the extracted data was performed, and the findings were presented.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At extraction, a total of 12,533 COVID-19-related studies were listed on the ICTRP portal. We included 9803 studies, after excluding 2060 duplicate records and 686 records without a site\/country. While 9347 studies (96%) were conducted outside of Africa, only 456 studies (4%) were conducted in the African continent, of which 270 (59.2%) were interventional studies, and 184 (40.4%) were observational studies. About 80% of the studies were conducted in Egypt and South Africa, and most of these involved testing of drugs and biologicals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The African continent hosts considerably fewer COVID-19-related research compared to other parts of the world. This may have implications on scientific evidence available for implementing COVID-19 control efforts. There is, therefore, a need for local funding and ownership of research projects and north-south collaboration in research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05621-x","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T18:03:25Z","timestamp":1633629805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP)"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-1542","authenticated-orcid":false,"given":"Bassey","family":"Edem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwuemeka","family":"Onwuchekwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ama","family":"Umesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Calnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"18","key":"5621_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med."},{"issue":"6","key":"5621_CR2","doi-asserted-by":"publisher","first-page":"e039978","DOI":"10.1136\/bmjopen-2020-039978","volume":"10","author":"HB Mehta","year":"2020","unstructured":"Mehta HB, Ehrhardt S, Moore TJ, Segal JB. Alexander GC. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. BMJ Open. 2020;10(6):e039978 [cited 2021 Jan 18] Available from: http:\/\/bmjopen.bmj.com\/.","journal-title":"BMJ Open"},{"issue":"9","key":"5621_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1003293","volume":"17","author":"S Juul","year":"2020","unstructured":"Juul S, Nielsen EE, Feinberg J, Siddiqui F, J\u00f8rgensen CK, Barot E, et al. Interventions for treatment of COVID-19: a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS Med. 2020;17(9):1\u201325. https:\/\/doi.org\/10.1371\/journal.pmed.1003293.","journal-title":"PLoS Med."},{"key":"5621_CR4","first-page":"1","volume":"9","author":"LG Hemkens","year":"2020","unstructured":"Hemkens LG, Janiaud P, Axfors C, van\u2019t Hooft J, Saccilotto R, Agarwal A, et al. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research. 2020;9:1\u201319.","journal-title":"F1000Research"},{"key":"5621_CR5","doi-asserted-by":"publisher","unstructured":"Edem B, Onwuchekwa C, Wariri O, Nkereuwem E, Nkereuwem OO, Williams V. Trends in clinical trial registration in sub-Saharan Africa between 2010 and 2020: a cross-sectional review of three clinical trial registries. Trials. 2021;22(1):1\u201311. Available from: https:\/\/doi.org\/https:\/\/doi.org\/10.1186\/s13063-021-05423-1","DOI":"10.1186\/s13063-021-05423-1"},{"key":"5621_CR6","doi-asserted-by":"crossref","unstructured":"Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015;5(9):6\u20137.","DOI":"10.1136\/bmjopen-2015-008932"},{"key":"5621_CR7","unstructured":"World Health Organization. International Clinical Trials Registry Platform (ICTRP) | primary registries [Internet]. WHO. World Health Organization; 2020 [cited 2020 Oct 18]. Available from: http:\/\/www.who.int\/ictrp\/network\/primary\/en\/"},{"key":"5621_CR8","unstructured":"International Committee of Medical Journal Editors. Clinical trials registration [Internet]. ICMJE. 2020 [cited 2020 May 21]. Available from: http:\/\/www.icmje.org\/about-icmje\/faqs\/clinical-trials-registration\/"},{"issue":"15","key":"5621_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1503\/cmaj.092252","volume":"182","author":"RJ Williams","year":"2010","unstructured":"Williams RJ, Tse T, Harlan WR, Zarin DA. Registration of observational studies: is it time? CMAJ. 2010;182(15):1638\u201342 [cited 2021 Apr 2] Available from: \/pmc\/articles\/PMC2952011\/.","journal-title":"CMAJ"},{"key":"5621_CR10","doi-asserted-by":"publisher","unstructured":"Chavers S, Fife D, Wacholtz M, Stang P, Berlin J. Registration of observational studies: perspectives from an industry-based epidemiology group. Pharmacoepidemiol Drug Saf. 2011;20(10):1009\u20131013. [cited 2021 Apr 3] Available from: https:\/\/onlinelibrary-wiley-com.ez.lshtm.ac.uk\/doi\/epdf\/https:\/\/doi.org\/10.1002\/pds.2221","DOI":"10.1002\/pds.2221"},{"key":"5621_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jclinepi.2015.09.009","volume":"70","author":"S Boccia","year":"2016","unstructured":"Boccia S, Rothman KJ, Panic N, Flacco ME, Rosso A, Pastorino R, et al. Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. J Clin Epidemiol. 2016;70:176\u201382 [cited 2021 Apr 3] Available from: https:\/\/www-sciencedirect-com.ez.lshtm.ac.uk\/science\/article\/pii\/S0895435615004321.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"5621_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/SHK.0000000000001565","volume":"54","author":"MF Osuchowski","year":"2020","unstructured":"Osuchowski MF, Aletti F, Cavaillon JM, Floh\u00e9 SB, Giamarellos-Bourboulis EJ, Huber-Lang M, et al. SARS-CoV-2\/COVID-19: evolving reality, global response, knowledge gaps, and opportunities. Shock. 2020;54(4):416\u201337 [cited 2021 Jan 19] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32433217\/.","journal-title":"Shock"},{"key":"5621_CR13","unstructured":"World Health Organization. A COORDINATED GLOBAL RESEARCH ROADMAP: 2019 NOVEL CORONAVIRUS [Internet]. Geneva; 2020 Mar [cited 2021 Jan 18]. Available from: https:\/\/www.glopid-r.org\/wp-content\/uploads\/2020\/03\/who-2019-novel-coronavirus-global-research-roadmap.pdf"},{"key":"5621_CR14","unstructured":"UK Collaborative on Development Research(UKCDR) & Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). COVID-19 research project tracker [Internet]. 2020 [cited 2021 Aug 17]. Available from: https:\/\/www.ukcdr.org.uk\/covid-circle\/covid-19-research-project-tracker\/"},{"key":"5621_CR15","first-page":"1047","volume":"4","author":"V Simpkin","year":"2019","unstructured":"Simpkin V, Namubiru-Mwaura E, Clarke L, Mossialos E. Investing in health R&D: where we are, what limits us, and how to make progress in Africa analysis. BMJ Glob Heal. 2019;4:1047 Available from: http:\/\/gh.bmj.com\/.","journal-title":"BMJ Glob Heal"},{"issue":"9","key":"5621_CR16","doi-asserted-by":"publisher","first-page":"e003454","DOI":"10.1136\/bmjgh-2020-003454","volume":"5","author":"P Idele","year":"2020","unstructured":"Idele P, Anthony D, You D, Luo C, Mofenson L. The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps. BMJ Glob Heal. 2020;5(9):e003454 [cited 2021 Jan 19] Available from: https:\/\/gh.bmj.com\/content\/5\/9\/e003454.","journal-title":"BMJ Glob Heal"},{"issue":"19","key":"5621_CR17","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMc2100362","volume":"384","author":"SSA Karim","year":"2021","unstructured":"Karim SSA, de Oliveira T. New SARS-CoV-2 variants\u2014clinical, public health, and vaccine implications. N Engl J Med. 2021;384(19):1866\u20138 [cited 2021 Aug 17] Available from: \/pmc\/articles\/PMC8008749\/.","journal-title":"N Engl J Med"},{"key":"5621_CR18","unstructured":"World Health Organization. WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access [Internet]. 2020 [cited 2021 Jan 19]. Available from: https:\/\/www.who.int\/news\/item\/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access"},{"issue":"19","key":"5621_CR19","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1056\/NEJMp2031373","volume":"383","author":"PR Krause","year":"2020","unstructured":"Krause PR, Gruber MF. Emergency Use Authorization of COVID vaccines - safety and efficacy follow-up considerations. N Engl J Med. 2020;383(19):e107 [cited 2021 Aug 17] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33064383\/.","journal-title":"N Engl J Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T18:03:48Z","timestamp":1633629828000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5621"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05621-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No patient-level data used in this study; therefore, ethics approval was neither required nor sought.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"682"}}